Companies · Other Health Care

Future Method, Inc.

NEW YORK · Other Health Care

Diligence memoA one-page analyst read on Future Method, Inc. — recommendation, valuation, rhythm, risks.
$2.0M
Total raised · real
3
Rounds
0.8×
Latest step-up
Top 55%
Sector rank · raised
Pre-Seed
Latest stage · inferred · Fri Jul 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Future Method, Inc. looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 1.90× the median modeled value of Pre-Seed Other Health Care companies in 2019–2021 (295 peers) — value vs value, same stage and era.
Dormant
  • Last raise 7.0 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Future Method, Inc. is one of 5376 Other Health Care companies tracked from NEW YORK. By capital raised it ranks mid-pack (ahead of 46% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
3
Investors (latest)
2017
Year incorporated
2019-07-19
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$13M$25M$38M$50MPre-Seed · 2018-02-07 Raised $850K (real) Modeled valuation $26M (est)$850K$26MPre-Seed2018Pre-Seed · 2018-09-07 Raised $650K (real) Modeled valuation $20M (est)$650K$20MPre-Seed2018Pre-Seed · 2019-07-19 Raised $500K (real) Modeled valuation $15M (est)$500K$15MPre-Seed2019+$650K+$500KCumulative $2.0M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$850K · 2018
Pre-Seed extension$650K · 2018
Pre-Seed extension$500K · 2019

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$15.4M
Base estimate est.
$313K
Conservative case
$174.7M
Upside case
$2.8M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seeda round under $1.0M). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $26.2M · 2018-02-072018Pre-Seed · modeled $20.0M · 2018-09-07Pre-Seed · modeled $15.4M · 2019-07-192019
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
28%
Survival probability
11% low · 52% high
1.64×/yr
Annual markup
2.23×/yr upside case
6.0 yr
Elapsed time used
7.0 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
9 mo
Avg between rounds
$1.4M/yr
Capital velocity
8.4 yr
On record since
2018
First round
3
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.8× of median
This company$2.0M
Sector median$2.4M
Latest round — vs other Pre-Seed rounds in sector (real $, this stage) 1.4× above median
This company$500K
Sector median$350K
Modeled value — vs sector median (estimate, all stages) 0.7× of median
This company$15.4M
Sector median$22.1M

Raised more than 46% of sector peers (real $). Modeled value above 43% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Pre-Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #73 of 295.

This companyCohort peer
$10.0M$100.0M$100K$1.0M$10.0MCapital raised (log)Aetas Co LLC · Pre-Seed Raised $1.0M · modeled $30.8M (est)Hauppauge SC Holdings, LLC · Pre-Seed Raised $995K · modeled $30.6M (est)Gateway IV Lithotripsy, LLC · Pre-Seed Raised $988K · modeled $30.4M (est)Endoscopy Center of West Central Ohio, LLC · Pre-Seed Raised $964K · modeled $29.7M (est)Dalent LLC · Pre-Seed Raised $1.9M · modeled $29.2M (est)FK Investor LLC · Pre-Seed Raised $940K · modeled $29.0M (est)Lynx Dx, Inc. · Pre-Seed Raised $925K · modeled $28.5M (est)Center at Arrowhead, LLC · Pre-Seed Raised $918K · modeled $28.3M (est)MedTek Valencia eCoin, LLC · Pre-Seed Raised $905K · modeled $27.9M (est)Westside PetWell, LLC · Pre-Seed Raised $900K · modeled $27.7M (est)Ulster Dialysis Partners, LLC · Pre-Seed Raised $930K · modeled $27.6M (est)DoveMed, Ltd. · Pre-Seed Raised $1.5M · modeled $26.5M (est)Future Method, Inc. (this company) Raised $2.0M · modeled $15.4M (est)Future Method, Inc.
CompanyStageRaised · realValue · estvs peer med.
Aetas Co LLCPre-Seed$1.0M$30.8M3.80×
Hauppauge SC Holdings, LLCPre-Seed$995K$30.6M3.78×
Gateway IV Lithotripsy, LLCPre-Seed$988K$30.4M3.76×
Endoscopy Center of West Central Ohio, LLCPre-Seed$964K$29.7M3.67×
Dalent LLCPre-Seed$1.9M$29.2M3.61×
FK Investor LLCPre-Seed$940K$29.0M3.58×
Lynx Dx, Inc.Pre-Seed$925K$28.5M3.52×
Center at Arrowhead, LLCPre-Seed$918K$28.3M3.49×
MedTek Valencia eCoin, LLCPre-Seed$905K$27.9M3.44×
Westside PetWell, LLCPre-Seed$900K$27.7M3.42×
Ulster Dialysis Partners, LLCPre-Seed$930K$27.6M3.40×
DoveMed, Ltd.Pre-Seed$1.5M$26.5M3.28×
Future Method, Inc. this companyPre-Seed$2.0M$15.4M1.90×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$850K2018-02-07$4.7M$26.2M90%
Pre-Seed$650K2018-09-07$3.6M$20.0M90%
Pre-Seed$500K2019-07-19$2.8M$15.4M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$850K2018-02-07
    • First recorded raise — entered as Pre-Seed.
    • 8 investors on this round.
  2. Pre-Seed$650K2018-09-07
    • Came back fast: 7 mo vs the ~14 mo sector norm.
    • Round 1.3× smaller than the prior — bridge or down round.
    • 2 investors on this round.
  3. Pre-Seed$500K2019-07-19
    • Raised 10 mo later, in step with the ~14 mo sector norm.
    • Round 1.3× smaller than the prior — bridge or down round.
    • 3 investors on this round.
Intelligence
2020 ~Q2
Modeled next raise · ~9mo cadence
$500K
Modeled next size est.range $500K$800K
0.8×
Last step-up
$1.4M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Eric Wilson3 other2019-07
BRIAN NOVACK1 other2018-02
Evan Goldstein2018-02
Registry & provenance

Future Method, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1732351
SEC CIK
2017
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Mobi, LlcOther Health CarePre-Seed$1.8M$17.7Msame sector · same stage
Nirvana Sciences, Inc.Other Health CarePre-Seed$1.7M$17.4Msame sector · same stage
enhancedcare, Inc.Other Health CarePre-Seed$1.6M$15.6Msame sector · same stage
Dentures Today, Inc.Other Health CarePre-Seed$1.6M$15.9Msame sector · same stage
DigitalVision LLCOther Health CarePre-Seed$1.6M$15.6Msame sector · same stage
SpineForm LLCOther Health CarePre-Seed$1.5M$16.8Msame sector · same stage
WhiteCloud Analytics, Inc.Other Health CarePre-Seed$1.5M$17.2Msame sector · same stage
Streamline, Inc.Other Health CarePre-Seed$1.5M$14.7Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Predictably Human, Inc.Other Health CareSeed$4.8M82%
Project Legacy, Inc.Other Health CareSeed$45.2M81%
NextGen Jane, Inc.Other Health CareSeries A$44.7M81%
NOWDiagnostics, Inc.Other Health CareSeries B$420.4M81%
2020, Inc.Other Health CareSeries A$82.4M81%
Mindsciences, Inc.Other Health CareSeed$60.5M81%
General Prognostics, Inc.Other Health CarePre-Seed$849K81%
Prescriber's Choice, Inc.Other Health CareSeed$31.8M81%
Frequently asked
How much funding has Future Method, Inc. raised?
Future Method, Inc. has raised approximately $2.0M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is Future Method, Inc.'s estimated valuation?
Provath's modeled valuation for Future Method, Inc. is approximately $15.4M (modeled range $313K–$174.7M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Future Method, Inc. at?
Future Method, Inc.'s latest modeled financing stage is Pre-Seed. Its most recent recorded round closed around Fri Jul 19.
What does Future Method, Inc. do and where is it based?
Future Method, Inc. operates in the Other Health Care sector, based in NEW YORK.
Explore related

See where Future Method, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Future Method, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.